April 27 (Reuters) - Medical device maker Boston Scientific Corp reported an 11 percent rise in quarterly revenue, boosted by higher sales of cardiovascular products, its biggest business.
The company’s net income was $202 million, or 15 cents per share, in the first quarter ended March 31.
In the year-earlier quarter, Boston Scientific had reported a net loss of $1 million, which included charges related to acquisition, litigation and restructuring.
Revenue rose to $1.96 billion from $1.77 billion. (Reporting by Amrutha Penumudi in Bengaluru; Editing by Anil D‘Silva)